Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age15+
SponsorPublic Health Foundation Enterprises, Inc.
About this trial
The purpose of this study is to compare the effectiveness of two mobile health technologies (text messaging or a mobile app) designed to help people take HIV pre-exposure prophylaxis (PrEP) as directed by the clinic. PrEP is the use of a daily anti-HIV medications by HIV-negative people to help prevent HIV infection.
Eligibility criteria
Qualifiers
Self-identifies as a cisgender man, transgender man (assigned female at birth, trans-masculine spectrum), or transgender woman (assigned male sex at birth, trans-feminine spectrum)
Report sex with a cisgender man or transgender woman or any individual assigned male sex at birth in the past 12 months
Age 15 years or older
Willing and able to provide written informed consent
Disqualifiers
Currently enrolled in another PrEP intervention study
Unable to complete 12 month study participation
Any medical, psychiatric, or social condition or other responsibilities that, in the judgment of the investigator, would make participation in the study unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
Trial design
Treatments tested in this trial
- PrEPmate
- Dot Diary
Treatment groups
300 Participants
are divided into 2 treatment groupsSponsors and collaborators
Public Health Foundation Enterprises, Inc.
Lead sponsor
Patient-Centered Outcomes Research Institute
Collaborator
University of California, San Francisco
Collaborator
University of Miami
Collaborator
Whitman-Walker Health
Collaborator
San Francisco AIDS Foundation
Collaborator
WelTel
Collaborator
San Francisco Department of Public Health
Collaborator
Source ClinicalTrials.gov